Our findings revealed elevated levels of the signaling pathway ligand, Wnt3a, as well as the key protein involved in this pathway, β-catenin, within cancer tissue compared to lower expression levels observed in adjacent noncancerous tissue (Fig. 7A,B), indicating an overactivation of the Wnt/ β-catenin signaling pathway. Here, WNT3A is linked to cancer.